logo

For the Inventor, By the Inventor

Thorndale, PA, United States of America

Laurent D Courvoisier

This inventor holds 16 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Cephalon, Inc., Cephalon France, Teva Sante. Active years: 2011-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurent D Courvoisier. Retrieved from https://idiyas.com/inventor/laurent-d-courvoisier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 68.8

 

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 87(Granted Patents)


Location History:

  • West Chester, PA (US) (2011)
  • Thorndale, PA (US) (2012 - 2019)
  • Garnet Valley, PA (US) (2018 - 2020)

Company Filing History:

goldMedal14 out of 248 
 
Cephalon, Inc.
 patents
silverMedal1 out of 20 
 
Cephalon France
 patents
bronzeMedal1 out of 8 
 
Teva Sante
 patents

Years Active: 2011-2020

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 10632119 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor (2020-04-28),
2. 10517852 - Solid forms of bendamustine hydrochloride (2019-12-31),
3. 10111872 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor (2018-10-30),
4. 10039750 - Solid forms of bendamustine hydrochloride (2018-08-07),
5. 9623026 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor (2017-04-18),
6. 9533955 - Solid forms of bendamustine hydrochloride (2017-01-03),
7. 9339502 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor (2016-05-17),
8. 9132128 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor (2015-09-15),
9. 8883836 - Solid forms of bendamustine hydrochloride (2014-11-11),
10. 8759583 - Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation (2014-06-24),
11. 8669279 - Solid forms of bendamustine hydrochloride (2014-03-11),
12. 8633314 - Forms of a multicyclic compound (2014-01-21),
13. 8513272 - Forms of a fused pyrrolocarbazole compound (2013-08-20),
14. 8445524 - Solid forms of bendamustine hydrochloride (2013-05-21),
15. 8318979 - Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation (2012-11-27),

Title: **The Innovative Journey of Laurent D Courvoisier**

Introduction

Laurent D Courvoisier is a prominent inventor based in Thorndale, PA, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 16 patents, Courvoisier has made strides in developing compounds aimed at addressing critical medical conditions.

Latest Patents

Among his most recent inventions is the "Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor." This innovative compound exhibits ALK and FAK inhibitory activity, providing a potential treatment option for proliferative disorders. In addition to this, he has also developed "Novel solid forms of bendamustine hydrochloride," which outlines methods for their preparation and application.

Career Highlights

Courvoisier's career has been marked by his work with notable companies such as Cephalon, Inc. and Cephalon France. His experience in these organizations has helped shape his expertise in drug development and innovation.

Collaborations

Throughout his career, Courvoisier has collaborated with esteemed colleagues, including Robert E McKean and Martin J Jacobs. These partnerships have been instrumental in advancing the research and development of his inventions.

Conclusion

Laurent D Courvoisier continues to be a driving force in the world of innovation, with his patents reflecting a commitment to improving medical treatments. His dedication to research and collaboration highlights the essential role inventors play in bringing new solutions to the healthcare industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…